title: Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in chronic myeloid leukemia: a single institution study.
authors.forename: Luciano
authors.initials: L
authors.lastname: Levato
authors.forename: Renato
authors.initials: R
authors.lastname: Cantaffa
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Kropp
authors.forename: Domenico
authors.initials: D
authors.lastname: Magro
authors.forename: Eugenio
authors.initials: E
authors.lastname: Piro
authors.forename: Stefano
authors.initials: S
authors.lastname: Molica
mesh_terms: D000368:Aged; D001157:Arterial Occlusive Diseases / Q000139:chemically induced* / Q000401:mortality; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D058729:Peripheral Arterial Disease / Q000139:chemically induced* / Q000401:mortality; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D012189:Retrospective Studies; D015996:Survival Rate
chemical_list: D011743:Pyrimidines; C498826:nilotinib